Pfizer-BioNTech COVID-19 vaccine for kids under 5 could be ready by end of February, according to The Washington Post
- A COVID-19
vaccinefor younger kids could be available by the end of February, according to The Washington Post.
- Pfizer-BioNTech is expected to submit an emergency use authorization request as soon as Tuesday.
A Pfizer-BioNTech two-shot regimen for younger kids could be ready in the coming weeks, people briefed on the situation told the outlet on Monday.
The companies are expected to submit a request for emergency use authorization to the Food and Drug Administration as soon as Tuesday, the newspaper reported. Pending approval, the shot would be available for children six months to 5 years old.
Sources told The Post that the FDA has pushed Pfizer and BioNTech to submit the application soon so regulators can start the review process.
Insider reached out to the FDA and the Centers for Disease Control and Prevention for comment.
This story is
- An overlooked group of borrowers will be hit hard as student loan repayments resume, former Fed economist says
- TikTok's strategy for US dominance is straight out of Amazon's playbook — but creators are the fuel for its flywheel
- Robin Williams' daughter says she finds AI recreations of her father's voice 'personally disturbing'
- Survey shows people find no improvement in public toilets across country
- Sebi extends deadline for listed cos to confirm or deny market rumours
- Tom Hanks, a dental plan promotion and an AI
- New 'inverse vaccine' shows potential to treat multiple sclerosis, diabetes: Study
- TDP leaders stage hunger strike In Delhi against arrest of Chandrababu Naidu